| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2025 | 2 May 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve the audited Financial Results of the Company for the Quarter and year ended on March 31 2025 Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2025 (As per BSE Announcement Dated on 09/05/2025) Outcome of Board meeting (As Per BSE Announcement dated on 27.05.2025) | ||
| Board Meeting | 1 Feb 2025 | 27 Jan 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31 2024. Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2024. Intimation of Investment in Axiodent Inc. (As Per BSE Announcement Dated on: 01/02/2025) | ||
| Board Meeting | 11 Nov 2024 | 4 Nov 2024 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter and half year ended on September 30 2024. To consider and approve the unaudited financial results of the Company for the quarter and half year ended on September 30, 2024 (As Per BSE Announcement dated on 11.11.2024) | ||
| Board Meeting | 27 Sep 2024 | 27 Sep 2024 |
| The Board of Directors at its meeting held on September 27, 2024 has approved the appointment of M/s. PAN & Associates as Cost Auditor of the Company for the F.Y. 2024-2025. | ||
| Board Meeting | 8 Aug 2024 | 31 Jul 2024 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve 1. To inter alia consider and approve the un-audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended on June 30 2024. 2. To recommend the Final Dividend for the Financial Year 2023-24. 3.To consider and approve the date time mode and Draft of AGM Notice for holding 25th Annual General Meeting of the Company through video conferencing (VC) / Other Audio-Visual Mechanism (OAVM) The Board of directors approved the unaudited financial results (Standalone and consolidated) for the quarter ended June 30, 2024 and recommended final dividend. Recommendation of payment of Final Dividend on Equity Shares at the rate of 10% (Ten per cent) [i.e.,1.00/- (Rupees One Only) per Equity Share of Face Value of 10/- (Rupees Ten Only)] for the Financial Year ended March 31, 2024, subject to approval of shareholders at the ensuing Annual General Meeting. The dividend, if approved, shall be paid within the prescribed timeline. The Board of directors approved the unaudited financial results (Standalone and consolidated) for the quarter ended June 30, 2024 and recommended final dividend. (As Per BSE Announcement Dated on 08.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.